Intracoronary fibrinolysis: An effective yet underutilized therapeutic strategy in clinical practice
Guardado en:
Autores principales: | Kenan Yalta, Cihan Öztürk, Tülin Yalta, Uğur Özkan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KARE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f44c2e5a1494caba340a4fdca550f77 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Accessory mitral valve tissue: An overview of clinical and practical implications
por: Kenan Yalta, et al.
Publicado: (2021) -
Apixaban for massive intracoronary thrombosis: A case series
por: Kerim Esenboğa, et al.
Publicado: (2021) -
Use of coagulation-fibrinolysis markers for prognostication of Stanford type A acute aortic dissection
por: Daisuke Arima MD, et al.
Publicado: (2021) -
A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Qian Zeng, et al.
Publicado: (2021) -
Anticoagulation in Peripheral Artery Disease: Are We There Yet?
por: Alessandro Cannavale, et al.
Publicado: (2020)